chr2-208443391-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005048.4(PTH2R):c.553G>A(p.Val185Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00033 in 1,610,052 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005048.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PTH2R | NM_005048.4 | c.553G>A | p.Val185Met | missense_variant | 6/13 | ENST00000272847.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PTH2R | ENST00000272847.7 | c.553G>A | p.Val185Met | missense_variant | 6/13 | 1 | NM_005048.4 | P1 | |
PTH2R | ENST00000617735.4 | c.220G>A | p.Val74Met | missense_variant | 6/13 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000381 AC: 58AN: 152124Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000587 AC: 145AN: 247166Hom.: 0 AF XY: 0.000569 AC XY: 76AN XY: 133660
GnomAD4 exome AF: 0.000324 AC: 473AN: 1457810Hom.: 0 Cov.: 30 AF XY: 0.000317 AC XY: 230AN XY: 725172
GnomAD4 genome AF: 0.000381 AC: 58AN: 152242Hom.: 0 Cov.: 33 AF XY: 0.000282 AC XY: 21AN XY: 74450
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 04, 2022 | The c.553G>A (p.V185M) alteration is located in exon 6 (coding exon 6) of the PTH2R gene. This alteration results from a G to A substitution at nucleotide position 553, causing the valine (V) at amino acid position 185 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
PTH2R-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 28, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at